Question 1

What is CEL-SCI Corporation?

Accepted Answer

CEL-SCI Corporation is a Company.

Question 2

How often does CEL-SCI Corporation appear in global news?

Accepted Answer

Tracked across 2 news events drawn from 12 articles.

Question 3

When was CEL-SCI Corporation first tracked by Ergen?

Accepted Answer

First tracked on May 12, 2026.

Question 4

When was CEL-SCI Corporation last mentioned in news?

Accepted Answer

Last active on Jun 24, 2026.

Question 5

What is CEL-SCI Corporation's current news sentiment?

Accepted Answer

Aggregate sentiment score: 42 on a -100 to +100 scale (negative = critical coverage, positive = favorable coverage).

Question 6

How prominent is CEL-SCI Corporation in global news coverage?

Accepted Answer

Attention score of 4, derived from article volume and coverage intensity across 2 events.

Question 7

What is the most recent event involving CEL-SCI Corporation?

Accepted Answer

CEL-SCI Closes Public Offering (May 12, 2026, 6 articles).

Question 8

How did the "CEL-SCI Closes Public Offering" event impact CEL-SCI Corporation?

Accepted Answer

CEL-SCI Corporation closed a public offering of 6,000,000 shares of its common stock, raising approximately $7.2 million in gross proceeds to fund the continued development of Multikine, general corporate purposes, and working capital.

Question 9

How did the "CEL-SCI, Saudi Amarox Sign Multikine Deal" event impact CEL-SCI Corporation?

Accepted Answer

CEL-SCI Corporation has entered into a strategic agreement with Saudi Amarox for the commercialization and distribution of its cancer immunotherapy, Multikine, in Saudi Arabia, which is a significant step towards expanding its market reach and potential revenue.

Question 10

How is this data collected?

Accepted Answer

Ergen aggregates thousands of global news sources and extracts structured events, entities, and relationships with sentiment and attention metrics. Pages are daily static snapshots from the platform's live database.